Publications for Helena Fohlin
Co-author map based on ISI articles 2007-

Publications mentioned in social media 20 times*

Journal Articles

Sverre Sörenson, Helena Fohlin, Andrea Lindgren, Magnus Lindskog, Bengt Bergman, Christer Sederholm, Lars Ek, Kristina Lamberg and Birgitta Clinchy
  Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
 
Altmetric usage: 1

  European Journal of Cancer, 2013, 49(1), 115-120.
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Helena Fohlin, Gizeh Perez-Tenorio, Tommy Fornander, Lambert Skoog, Bo Nordenskjöld, John Carstensen and Olle Stål
  Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer
 
Altmetric usage: 1

  European Journal of Cancer, 2013, 49(6), 1196-1204.
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Laszlo Tabar, Bedrich Vitak, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Anders Cohen, Tibor Tot, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, Jean Ching-Yuan Fann, Johan Rosell, Helena Fohlin, Robert A Smith and Stephen W Duffy
  Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
 
Altmetric usage: 18

  Radiology, 2011, 260(3), 658-663.
 Web of Science® Times Cited: 87

Mahmoud R Khoshnoud, Britta Lofdahl, Helena Fohlin, Tommy Fornander, Olle Stål, Lambert Skoog, Jonas Bergh and Bo Nordenskjöld
  Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
  Breast Cancer Research and Treatment, 2011, 126(2), 421-430.
 Web of Science® Times Cited: 13

Andrea Koch, Bertil Gustafsson, Helena Fohlin and Sverre Sörenson
  Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry
  Diagnostic Cytopathology, 2011, 39(3), 188-193.
 Web of Science® Times Cited: 4

B. C. Sanchez, M. Sundqvist, Helena Fohlin, F. Spyratos, Bo Nordenskjöld, Olle Stål, B. K and Linderholm
  Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF
  European Journal of Cancer, 2010, 46(9), 1580-1587.
 Web of Science® Times Cited: 4

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.